Status: Not yet recruiting
Metformin in Parkinson's Disease: Safety and Efficacy
This study will evaluate whether metformin when it will be given to patients with Parkinson's disease along with standard therapy (levodopa carbidopa) will improve motor symptoms and decreases levels of alpha synuclein and MDA in patients with PD as compare to PD patients receiving only standard therapy (levodopa carbidopa)
Participants needed: 70
Trial details
Phase: Phase 4Age: 50-70Biological sex: AllType: InterventionalSponsor: Jinnah Medical & Dental CollegeUpdated: Sep 9, 2026
Eligibility criteria
Not listed